Risk of atrial tachycardias after covid-19: nationwide self-controlled cases series and matched cohort study.

Back

ESC Professional Premium Access

Risk of atrial tachycardias after covid-19: nationwide self-controlled cases series and matched cohort study.

Session: Risks and effects of interventions on prognosis and outcome in atrial fibrillation

Topic: Prevalence and Incidence of Atrial Fibrillation

Speaker: Doctor I. Katsoularis (Umea, SE)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Ioannis Katsoularis

Umea University Hospital, Umea (Sweden)

1 presentation

0 follower

5 more presentations in this session

Risk of incident atrial fibrillation and subsequent use of oral anticoagulants in patients with dementia

Speaker: Doctor T. Chao (Taipei, TW)

Oral anticoagulant use and outcomes in Asian patients with atrial fibrillation in the GLORIA-AF Registry

Speaker: Doctor G. Romiti (Rome, IT)

Amiodarone is associated with increased mortality compared with other antiarrhythmic drugs in female patients with atrial fibrillation

Speaker: Professor J. Choi (Seoul, KR)

AF in the AFternoon: The circadian pattern of incident atrial fibrillation in a loop recorder population

Speaker: Doctor P. Chousou (Cambridge, GB)

Associations of adding salt to foods with incident atrial fibrillation in the UK biobank study

Speaker: Doctor Y. Park (Daegu, KR)

Access the full session

Risks and effects of interventions on prognosis and outcome in atrial fibrillation

Speakers: Doctor I. Katsoularis, Doctor T. Chao, Doctor G. Romiti, Professor J. Choi, Doctor P. Chousou...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources